Advancing the frontiers of clinical drug development

CHDR is an independent institute specialising in innovative early-stage clinical drug research.

Our Story Our Unit


New publication: A Large-Scale Full GBA1 Gene Screening in Parkinson's Disease i...

16 Jul 2020

Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recur...

26 Jul 2020

Interested to join our team? Browse the latest openings

Combining innovative methods with state-of-the-art facilities maximises our clients' chance of success

CHDR has developed and validated an accurate intravenous ethanol infusion procedure to study the effects of ethanol interaction

Performing a multicentre study is usually not the ideal way to collect all of the data needed in the early stages of clinical drug development

A safer way to measure the effects of drugs and disease on driving performance